Microbiology tests in Dubai & UAE

Compare available Microbiology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

299

Listed price range

490.00–5,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Microbiology test prices

Showing 61–75 of 299 matching tests.

Microbiology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-862 Cultured AFB Antitubercular Drug Susceptibility Testing (DST) — Amikacin Test This test determines the minimum inhibitory concentration (MIC) of Amikacin against a pure culture of Mycobacterium tuberculosis complex.	Pure growth of Mycobacterium tuberculosis complex on solid or liquid media	21 days from receipt of pure culture isolate	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Minimum Inhibitory Concentration (MIC) of Amikacin", "Phenotypic susceptibility to Amikacin"] Parameters [{"name": "Amikacin Minimum Inhibitory Concentration (MIC)", "reference_range": "Susceptible (S), Intermediate (I), Resistant (R) based on established breakpoints"}] Preparation ["No direct patient preparation required as the test is performed on a cultured isolate."] Indications ["Guiding Category IV MDR-TB regimens", "Confirming Amikacin susceptibility before prolonged parenteral therapy", "Detecting all resistance mechanisms, including novel variants"] Measurement technique Confirm with laboratory Codes LOINC: 20454-0 ICD-10: Z16.21 Clinical summary This test determines the minimum inhibitory concentration (MIC) of Amikacin against a pure culture of Mycobacterium tuberculosis complex.
TEST-899 Cultured AFB Antitubercular DST (Rapid 11-Drugs Panel) Test This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to 11 key anti-tubercular drugs using automated fluorometric growth-based detection.	Pure culture isolate of Mycobacterium tuberculosis complex	21 Days (report post-incubation of submitted pure culture)	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid", "Susceptibility to Rifampicin", "Susceptibility to Pyrazinamide", "Susceptibility to Ethambutol", "Susceptibility to Fluoroquinolones", "Susceptibility to Aminoglycosides", "Susceptibility to Injectables"] Parameters [{"name": "Isoniazid", "reference_range": "Susceptible/Resistant"}, {"name": "Rifampicin", "reference_range": "Susceptible/Resistant"}, {"name": "Pyrazinamide", "reference_range": "Susceptible/Resistant"}, {"name": "Ethambutol", "reference_range": "Susceptible/Resistant"}, {"name": "Fluoroquinolones", "reference_range": "Susceptible/Resistant"}, {"name": "Aminoglycosides", "reference_range": "Susceptible/Resistant"}, {"name": "Injectables", "reference_range": "Susceptible/Resistant"}] Preparation ["No specific patient preparation required; sample collection is hospital-based."] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for treatment selection in MDR-TB cases", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 53501-2 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to 11 key anti-tubercular drugs using automated fluorometric growth-based detection.
TEST-878 Cultured AFB Antitubercular DST Ethambutol Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antitubercular drug ethambutol.	Mycobacterial Culture Isolate (from respiratory or extrapulmonary specimen)	21 Days from Receipt of Pure Isolate	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Phenotypic resistance or sensitivity of Mycobacterium tuberculosis to ethambutol"] Parameters [] Preparation [] Indications ["Diagnosis of active tuberculosis", "Monitoring treatment response", "Guiding therapy in drug-resistant TB cases", "Baseline susceptibility testing per UAE National TB Program guidelines"] Measurement technique Confirm with laboratory Codes LOINC: 29579-0 ICD-10: Z16.24, A15.0, Z15.89 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antitubercular drug ethambutol.
TEST-883 Cultured AFB Antitubercular DST Linezolid Test This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to the antibiotic linezolid.	Pure culture isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture isolate	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Minimum Inhibitory Concentration (MIC) of Linezolid", "Phenotypic drug susceptibility"] Parameters [{"name": "Minimum Inhibitory Concentration (MIC)", "reference_range": null}] Preparation ["Ensure a pure culture isolate is available", "Coordinate specimen collection timing if patient is on linezolid"] Indications ["Diagnosis of drug-resistant tuberculosis (MDR-TB, XDR-TB)", "Guidance for linezolid therapy selection", "Surveillance of antimicrobial resistance"] Measurement technique Confirm with laboratory Codes LOINC: 100342-9 ICD-10: A15.0, Z16.31 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to the antibiotic linezolid.
TEST-893 Cultured AFB Antitubercular DST Rapid 10-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to ten antitubercular drugs.	Mycobacterium tuberculosis complex pure culture isolate	21 working days from receipt of pure culture	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid (INH)", "Susceptibility to Rifampicin (RIF)", "Susceptibility to Ethambutol (EMB)", "Susceptibility to Pyrazinamide (PZA)", "Susceptibility to Moxifloxacin", "Susceptibility to Linezolid", "Susceptibility to other relevant drugs"] Parameters [{"name": "Isoniazid (INH)", "reference_range": "Susceptible/Resistant"}, {"name": "Rifampicin (RIF)", "reference_range": "Susceptible/Resistant"}, {"name": "Ethambutol (EMB)", "reference_range": "Susceptible/Resistant"}, {"name": "Pyrazinamide (PZA)", "reference_range": "Susceptible/Resistant"}, {"name": "Moxifloxacin", "reference_range": "Susceptible/Resistant"}, {"name": "Linezolid", "reference_range": "Susceptible/Resistant"}] Preparation ["No special patient preparation is necessary as the test is performed on a laboratory-grown pure isolate."] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for initial tuberculosis therapy", "Monitoring for acquired drug resistance"] Measurement technique Confirm with laboratory Codes LOINC: 49850-1 ICD-10: Z16.24, A15.0 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to ten antitubercular drugs.
TEST-897 Cultured AFB Antitubercular DST Rapid 12-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to 12 anti-tuberculosis drugs.	Isolated Mycobacterium tuberculosis complex culture	21 days from receipt of culture isolate	2,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 12 anti-tuberculosis drugs", "Minimum Inhibitory Concentration (MIC)"] Parameters [{"name": "Bedaquiline", "reference_range": null}, {"name": "Linezolid", "reference_range": null}, {"name": "Clofazimine", "reference_range": null}, {"name": "Fluoroquinolones", "reference_range": null}, {"name": "Isoniazid", "reference_range": null}, {"name": "Rifampicin", "reference_range": null}, {"name": "Pyrazinamide", "reference_range": null}, {"name": "Ethambutol", "reference_range": null}, {"name": "Streptomycin", "reference_range": null}, {"name": "Amikacin", "reference_range": null}, {"name": "Moxifloxacin", "reference_range": null}, {"name": "Levofloxacin", "reference_range": null}] Preparation ["No special patient preparation is required.", "A pure culture isolate is needed."] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for treatment selection in confirmed tuberculosis cases", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 52829-4 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to 12 anti-tuberculosis drugs.
TEST-908 Cultured AFB Antitubercular DST Rapid 15 Drugs Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to 15 antitubercular drugs.	Sputum or Culture Isolate	21 days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 15 antitubercular drugs", "Minimum Inhibitory Concentration (MIC) for each drug"] Parameters [] Preparation ["Collect a respiratory specimen (e.g., sputum) early in the morning.", "Rinse mouth with water before providing a deep cough sample.", "Alternatively, send a cultured bacterial isolate."] Indications ["Diagnosis of tuberculosis", "Determination of drug resistance patterns", "Guidance for treatment selection"] Measurement technique Confirm with laboratory Codes LOINC: 82356-5 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to 15 antitubercular drugs.
TEST-902 Cultured AFB Antitubercular DST Rapid 16‑Drugs Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 16 anti-TB drugs.	Mycobacterium tuberculosis complex culture isolate (pure growth)	21 days from pure culture submission	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 16 anti-TB drugs", "Phenotypic drug resistance patterns"] Parameters [] Preparation ["No personal preparation is needed as the test is performed on a pre-grown culture."] Indications ["Diagnosis of drug-resistant tuberculosis (MDR/XDR-TB)", "Guidance for personalized anti-TB treatment regimens", "Monitoring treatment response in complex cases"] Measurement technique Confirm with laboratory Codes LOINC: 60535-9 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 16 anti-TB drugs.
TEST-923 Cultured AFB Antitubercular DST Rapid 19-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis to 19 antitubercular drugs.	Cultured Mycobacterium tuberculosis isolate	21 calendar days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 19 antitubercular drugs", "Drug resistance profile"] Parameters [] Preparation [] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for antitubercular therapy selection", "Surveillance of drug resistance patterns"] Measurement technique Confirm with laboratory Codes LOINC: 101468-0 ICD-10: Z01.89 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis to 19 antitubercular drugs.
TEST-916 Cultured AFB Antitubercular DST Rapid Second‑Line Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to five critical second-line antitubercular drugs using an automated phenotypic method.	Pure, viable Mycobacterium tuberculosis complex isolate (archival specimen)	21 days from receipt of pure culture	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid", "Susceptibility to Rifampicin", "Susceptibility to Fluoroquinolones", "Susceptibility to Injectable Agents", "Susceptibility to Ethambutol"] Parameters [] Preparation ["No patient preparation is needed."] Indications ["Suspected or confirmed MDR-TB", "Prior exposure to second-line TB drugs", "Failure of first-line TB treatment", "Need for personalized MDR-TB therapy"] Measurement technique Confirm with laboratory Codes LOINC: 100936-3 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to five critical second-line antitubercular drugs using an automated phenotypic method.
TEST-891 Cultured AFB Antitubercular DST Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antibiotic moxifloxacin.	Pure Culture Isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture isolate	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Moxifloxacin susceptibility", "Mycobacterium tuberculosis resistance profile"] Parameters [] Preparation ["No patient preparation required; sample is a pure culture isolate."] Indications ["Diagnosis of MDR-TB", "Guidance for MDR-TB treatment regimens", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 94030-1 ICD-10: U84.0, A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antibiotic moxifloxacin.
TEST-896 Cultured AFB Antitubercular PAS Drug Susceptibility Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to the antitubercular drug p-aminosalicylic acid (PAS).	Pure culture isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture isolate	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["In-vitro susceptibility of Mycobacterium tuberculosis complex to p-aminosalicylic acid (PAS)", "Minimum Inhibitory Concentration (MIC) for PAS"] Parameters [] Preparation [] Indications ["Suspected or confirmed MDR-TB", "Need to guide second-line antitubercular therapy", "Monitoring treatment response in MDR-TB cases"] Measurement technique Confirm with laboratory Codes LOINC: 50525-3 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to the antitubercular drug p-aminosalicylic acid (PAS).
TEST-919 Cultured AFB Drug Resistance (Anti‑Tubercular DST) Rapid 15‑Drug Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 15 different anti-tubercular drugs.	Cultured Isolate (Mycobacterium tuberculosis complex) on solid/liquid media	21 days	2,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 15 anti-tubercular agents", "Mycobacterium tuberculosis drug resistance profile"] Parameters [] Preparation [] Indications ["Diagnosis of drug-resistant tuberculosis (MDR-TB, XDR-TB)", "Guidance for personalized anti-tubercular therapy", "Monitoring treatment response in complex cases"] Measurement technique Confirm with laboratory Codes LOINC: 88122-7 ICD-10: A15.0, Z16.3 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 15 different anti-tubercular drugs.
TEST-861 Cultured AFB Other Than Tuberculosis (MOTT) Drug Susceptibility Testing (DST) for Slow Growers Test This test evaluates the susceptibility of slow-growing nontuberculous mycobacteria (MOTT) to various antimycobacterial drugs using a broth microdilution method.	Pure culture isolate of slow-growing nontuberculous mycobacteria (MOTT)	14 Working Days from pure culture isolate submission	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Minimal Inhibitory Concentration (MIC) of antimycobacterial drugs", "Susceptibility of slow-growing MOTT isolates"] Parameters [] Preparation ["No special patient preparation is required for the culture isolate submission."] Indications ["Suspected infection with slow-growing nontuberculous mycobacteria (MOTT)", "Need to guide antibiotic therapy for MOTT infection", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 100337-6 ICD-10: A31.9, A31.0 Clinical summary This test evaluates the susceptibility of slow-growing nontuberculous mycobacteria (MOTT) to various antimycobacterial drugs using a broth microdilution method.
TEST-904 Cultured AFB Second-Line Antitubercular Drug Susceptibility Test (DST) Panel This test evaluates the susceptibility of Mycobacterium tuberculosis to a panel of ten second-line antitubercular drugs using phenotypic culture methods.	Sputum (Respiratory Specimen)	21 days from pure culture	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Phenotypic resistance to fluoroquinolones", "Phenotypic resistance to injectable agents", "Phenotypic resistance to other second-line drugs"] Parameters [{"name": "Amikacin", "reference_range": "Susceptible/Resistant"}, {"name": "Kanamycin", "reference_range": "Susceptible/Resistant"}, {"name": "Capreomycin", "reference_range": "Susceptible/Resistant"}, {"name": "Ofloxacin", "reference_range": "Susceptible/Resistant"}, {"name": "Levofloxacin", "reference_range": "Susceptible/Resistant"}, {"name": "Moxifloxacin", "reference_range": "Susceptible/Resistant"}, {"name": "Ethionamide", "reference_range": "Susceptible/Resistant"}, {"name": "Linezolid", "reference_range": "Susceptible/Resistant"}, {"name": "Clofazimine", "reference_range": "Susceptible/Resistant"}, {"name": "Bedaquiline", "reference_range": "Susceptible/Resistant"}] Preparation ["No fasting or special preparation is needed", "Collect sputum sample first thing in the morning"] Indications ["Confirmation of MDR-TB", "Guidance for second-line drug regimen selection", "Monitoring treatment response in MDR-TB"] Measurement technique Confirm with laboratory Codes LOINC: 60567-6 ICD-10: Z16.24, Z16.29 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis to a panel of ten second-line antitubercular drugs using phenotypic culture methods.

Category overview

Microbiology: overview

Uncovering the hidden causes of illness is the essential first step toward targeted treatment and restoring your peace of mind. The Microbiology division at DNA Labs UAE employs advanced automated culturing and antimicrobial susceptibility technologies to identify specific microscopic pathogens accurately. By pinpointing the exact bacteria or fungi involved, our comprehensive microbiology testing in the UAE serves as a vital guide for your doctor’s clinical decision-making. Operating as a premier diagnostic lab in Dubai/UAE, we guarantee the highest standards of data security and strict confidentiality, delivering fast, highly accurate results you can rely on. Take the guesswork out of your recovery. Browse our microbiology diagnostic tests, schedule a convenient home collection, or speak with our laboratory experts today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Microbiology tests in Dubai & UAE

Microbiology test prices

Microbiology: overview

Use the test details as a conversation starter

Related Microbiology categories